Full Text
HPR77 Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023

Abstract

Authors

Elisabet Viayna Edward J. CaJacob III M. Chris Runken

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×